Cover ImageSALE
市場調查報告書

臉部注射劑的全球市場:2016∼2020年

Global Facial Injectables Market 2016-2020

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 373858
出版日期 內容資訊 英文 80 Pages
訂單完成後即時交付
價格
Back to Top
臉部注射劑的全球市場:2016∼2020年 Global Facial Injectables Market 2016-2020
出版日期: 2016年10月03日 內容資訊: 英文 80 Pages
簡介

注射劑是在臉部美容採用的皮膚用填充物與肉毒桿菌,有除皺紋讓皮膚光滑而變年輕的重要作用。全球臉部注射劑市場,預計2016∼2020年以9.75%的年複合成長率擴大。

本報告提供全球臉部注射劑市場相關調查,市場現狀及成長預測,市場規模,各市場區隔趨勢,各地區趨勢,及主要供應商簡介等彙整資料。

第1章 摘要整理

第2章 本報告的範圍

第3章 市場調查方法

第4章 簡介

第5章 臉部注射劑:概要

  • 定義
  • 背景
  • 注射劑的種類

第6章 市場情況

  • 全球市場
  • 市場規模與預測
  • 波特的五力分析

第7章 各產品市場區隔

第8章 全球肉毒桿菌市場

第9章 全球皮膚用填充物市場

第10章 各地區市場區隔

  • 南北美洲
  • 歐洲、中東、非洲
  • 亞太地區

第11章 推動市場的要素

  • 從侵入性轉變為微創及非侵入性手術
  • 消費者的美容意識提高
  • 來自老年人的臉部注射劑需求擴大
  • 抗老化相關的意識提升

第12章 促進要素的影響

第13章 市場課題

  • 臉部注射劑的副作用
  • 產品成本高
  • 假產品的威脅
  • 政府的法律規章的擴大

第14章 促進要素與課題的影響

第15章 市場趨勢

第16章 供應商環境

  • 競爭模式
  • 投資機會分析

第17章 主要供應商分析

  • Allergan
  • Bloomage BioTechnology
  • Galderma
  • Merz Aesthetics
  • 其他值得注意的供應商

第18章 附錄

第19章 關於Technavio

目錄
Product Code: IRTNTR10272

About Injectables

Injectables are a combination of dermal fillers and Botox used in facial aesthetic treatments, which help reduce wrinkles and play a crucial role in rejuvenating facial skin for smoother and younger look. These are injected under the skin or lips to plump up the tissues and gently lift it to restore collagen lost due to aging. Collagen and HA provide essential support to skin and help it retain its elasticity. The glabellar lines, wrinkles, and lines can be reduced with facial aesthetic treatment.

Technavio's analysts forecast the global facial injectables market to grow at a CAGR of 9.75% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global facial injectables market for 2016-2020. To calculate the market size, the report considers the revenue generated through the sales of injectables.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Facial Injectables Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Allergan
  • Bloomage BioTechnology
  • Galderma
  • Merz Aesthetics

Other Prominent Vendors

  • AQTIS Medical
  • ColBar LifeScience
  • Hangzhou Techderm Biological Products
  • Laboratory Obvieline
  • Medytox
  • Polymekon
  • Qufu Guanglong Biochem
  • Revitacare
  • Suneva Medical
  • SciVision Biotech
  • Speciality European Pharma
  • Syneron
  • Visionmed

Market driver

  • Growing demand for facial injectables among older population
  • For a full, detailed list, view our report

Market challenge

  • High cost of products
  • For a full, detailed list, view our report

Market trend

  • Emergence of combination treatments
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01:Executive summary

  • Highlights

PART 02:Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03:Market research methodology

  • Research methodology
  • Economic indicators

PART 04:Introduction

  • Key market highlights

PART 05:Facial injectables: An overview

  • Definition: Facial injectables
  • Background
  • Types of injectables

PART 06:Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 07:Market segmentation by product

PART 08:Global facial injectables market by Botox

  • Market overview
  • Market size and forecast

PART 09:Global facial injectables market by dermal fillers

  • Market overview
  • Market size and forecast

PART 10:Geographical segmentation

  • Facial injectables market in Americas
  • Facial injectables market in EMEA
  • Facial injectables market in APAC

PART 11:Market drivers

  • Shift from invasive to minimally invasive and non-invasive procedures
  • Increase in beauty consciousness among consumers
  • Growing demand for facial injectables among older population
  • Increased awareness about anti-aging measures

PART 12:Impact of drivers

PART 13:Market challenges

  • Side effects associated with facial injectables
  • High cost of products
  • Threat of counterfeit products
  • Increase in government regulations

PART 14:Impact of drivers and challenges

PART 15:Market trends

  • Advances in technology
  • Rise in medical tourism
  • Emergence of combination treatments

PART 16:Vendor landscape

  • Competitive scenario
  • Investment opportunity analysis

PART 17:Key vendor analysis

  • Allergan
  • Bloomage BioTechnology
  • Galderma
  • Merz Aesthetics
  • Other prominent vendors

PART 18:Appendix

  • List of abbreviations

PART 19:Explore Technavio

List of Exhibits

  • Exhibit 01:Product offerings
  • Exhibit 02:Snapshot of global facial injectables market 2015-2020
  • Exhibit 03:Countries that performed highest number of cosmetic surgeries 2014
  • Exhibit 04:Countries with high number of cosmetic surgeons 2014
  • Exhibit 05:Market segmentation by material type
  • Exhibit 06:Steps involved in facial injectable filler procedures
  • Exhibit 07:Global facial injectables market analysis: Developed and emerging countries
  • Exhibit 08:Global facial injectables market 2015-2020 ($ billions)
  • Exhibit 09:Opportunity analysis: Global facial injectables market
  • Exhibit 10:Five forces analysis
  • Exhibit 11:Global facial injectables market segmentation by product type
  • Exhibit 12:Global facial injectables market by product type 2015-2020
  • Exhibit 13:Global facial injectables market: Product analysis 2015
  • Exhibit 14:Market growth lifecycle analysis for dermal fillers and Botox 2015
  • Exhibit 15:Global facial injectables market by product 2015-2020 ($ billions)
  • Exhibit 16:Global facial injectables market by product 2015-2020 (%)
  • Exhibit 17:Opportunity analysis of global Botox market
  • Exhibit 18:Global Botox market 2015-2020 ($ billions)
  • Exhibit 19:Botulinum toxin procedures in few major countries 2014
  • Exhibit 20:Global dermal fillers market: Opportunity analysis
  • Exhibit 21:Global dermal fillers market 2015-2020 ($ billions)
  • Exhibit 22:Global facial injectables market by product type 2015-2020 ($ billions)
  • Exhibit 23:Global facial injectables market by product type 2015-2020 (%)
  • Exhibit 24:Global facial injectables market by geography 2015-2020
  • Exhibit 25:Global facial injectables market by geography 2015-2020
  • Exhibit 26:Geographical presence of facial injectables market
  • Exhibit 27:Global facial injectables market analysis by geography
  • Exhibit 28:Facial injectables market in Americas 2015-2020 ($ billions)
  • Exhibit 29:Facial injectables market in EMEA 2015-2020 ($ billions)
  • Exhibit 30:Facial injectables market in APAC 2015-2020 ($ billions)
  • Exhibit 31:Global facial injectables market by geography 2015-2020 ($ billions)
  • Exhibit 32:Global facial injectables market by geography 2015-2020 (%)
  • Exhibit 33:Top five cosmetic minimally-invasive procedures 2014 and percentage comparison from 2013
  • Exhibit 34:Annual average disposable income of employees by countries 2014 ($)
  • Exhibit 35:Impact of drivers
  • Exhibit 36:Average cost of dermal facial fillers
  • Exhibit 37:Average cost of Botox
  • Exhibit 38:Impact of drivers and challenges
  • Exhibit 39:Investment potential mapping for vendors in different countries
  • Exhibit 40:Allergan: Strength analysis
  • Exhibit 41:Allergan: Growth strategy matrix
  • Exhibit 42:Allergan.: Opportunity assessment
  • Exhibit 43:Bloomage BioTechnology: Strength analysis
  • Exhibit 44:Bloomage BioTechnology: Growth strategy matrix
  • Exhibit 45:Bloomage BioTechnology: Opportunity assessment
  • Exhibit 46:Galderma: Strength analysis
  • Exhibit 47:Galderma: Growth strategy matrix
  • Exhibit 48:Galderma: Opportunity assessment
  • Exhibit 49:Merz Aesthetics: Strength analysis
  • Exhibit 50:Merz Aesthetics: Growth strategy matrix
  • Exhibit 51:Merz Aesthetics: Opportunity assessment
Back to Top